Close  
Diabetic Foot Ulcer Solutions

Diabetic Foot Ulcer (DFU) solutions

Connect with a 3M Account Representative
  • Research has shown that patients with diabetes have up to a 25% lifetime risk of diabetic foot ulceration (DFU), one of the most frequently recognized complications of diabetes.¹ DFUs are the leading non-traumatic cause of lower extremity foot amputations worldwide.²

    Every wound is unique and may require a cascading approach to treatment. It has been demonstrated that early initiation* of our Negative Pressure Wound Therapy can reduce time to significant closure by up to 50% for acute wounds and 67% for chronic wounds.** We also offer a full suite of Advanced Wound Dressings and Skin Integrity Solutions to help your patients complete their journey to healing.

    *Defined as treatment within the first 7 days for acute wound and 30 days for chronic wounds from the first wound treatment date.
    ** Based on a retrospective analysis conducted on a national insurance provider’s medical claims data, which examined 6,181 acute and 1,480 chronic wound patients that received NPWT from January 1, 2009 to June 30, 2011.


  • Icon of stack of money with cost
    $9-13 billion in additional costs

    An estimated $9-13 billion is spent to treat DFUs in the United States healthcare system annually¹.

  • Icon of 25%
    15-25% lifetime risk

    People with diabetes have a 15-25% lifetime risk of developing DFUs³.

  • Icon of an upward arrow with risk of death
    2.5x higher risk of death

    Patients with a DFU have a 2.5x higher risk of death at five years than patients without a DFU⁴.

Solutions for Managing DFUs brochure thumbnail
To learn more about solutions for managing DFUs, download the brochure
Download the brochure (PDF, 1.20 MB)

NOTE: Specific indications, contraindications, warnings, precautions, and safety information exist for these products and therapies, some of which may be Rx only. Please consult a clinician and product instruction for use prior to application.


A doctor wearing a stethoscope, speaking with a patient.
Get the answers you need
Contact a 3M Account Representative
  • NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies, some of which may be Rx only. Please consult a clinician and product instruction for use prior to application.

References

1. Bradford Rice J, Desai U, et al. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care 2014; 37:651–658.
2. Hingorani, A., LaMuraglia, G. M., Henke, P., Meissner, M. H., Loretz, L., Zinszer, K. M., ... & Mills Sr, J. L. (2016). The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of vascular surgery, 63(2), 3S-21S.
3. Singh N, Armstrong DA, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-28.
4. Armstrong D, Boulton M.D., Bus S. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med, 2017; 376;24.